![Pharmeasy [CPS] IN](https://cdn.admitad-connect.com/public/campaign/images/2020/12/29/23369-568909704dd2336f.png "Pharmeasy [CPS] IN")
-
EPC
1 050₹
-
CR
8.91%
-
CR for 48 hours
10.80%
-
Approval rate
73%
-
Cookie lifetime
30 days
-
Avg. hold time
37 days
-
Average payment time
54 days
Banners and Links
Warning! Codes and links will become available after you join the selected ad space to this program.
Default affiliate link
"Dynamic ads" tool shows ads for AliExpress products to the users based on their browsing behavior on AliExpress.com and the content of your website so that users see ads for only those products that they are interested in. Such targeting helps to increase the click-through rate of your ad and thus your reward. You can find more information about this tool in Help Center.
Product Feeds
Warning! Please join the program to download a product feed.
Here you can get a link to original product feed of this program. Links in product descriptions have been replaced by deeplinks. Time of last updating has also been added.
Products: Updated: Updated by advertiser:
Landing pages
Warning! Codes and links will become available after you join the selected ad space to this program.
This section provides the rating of landing pages of this affiliate program. You can learn and compare the average cost for click and conversion rates of different landing pages, or get links to them.
Program review
Why Admitad?
- detail analytics and useful tools,
- Fee-free express payment,
- enormous range of affiliate programs,
- trusted by 934839 publishers,
- and much more.
This affiliate program is a part of the Admitad affiliate network
In order to start cooperation with the program, first you need to register in the system.
Company’s description: Pharmacy is one of the largest pharmacy aggregators in India. They help patients connect with local pharmacy stores and diagnostic centres in order to fulfil their extensive medical needs. We believe that everyone should have access to good health. Thus, through our services, we ensure you get access to the best and most genuine health products, with the highest savings in the shortest time possible.
Campaign’s description: The campaign needs to be promoted on CPS (cost per sale) where the validation will be done on delivered orders. Pharmeasy CPFT is the website campaign which provides an opportunity to the affiliates to earn good revenue, if the transaction is made with the affiliate link. It is the Cost per first transaction campaign
Web campaign brief:
Campaign Name – CPS
Campaign Type - Medicine
Billable event – Successful Sale
AOV – Above Rs.1000/- (Hard KPI)
Geo-Targeting - PAN India
Age Group – 20+
Campaign’s objective: To generate sales.
Please Note: Affiliates are allowed to only promote the coupons/ offers provided Admitad or those available on the website (Pharmeasy). No other coupon codes being promoted or redeemed will be payable.
Basics
Cost per Transaction - We have to generate new sale for this campaign
Please Note: Affiliates are allowed to only promote the coupons/ offers provided Admitad or those available on the website (Pharmeasy). No other coupon codes being promoted or redeemed will be payable.
Below paid search terms are not allowed:
- Bidding on branded/trademarked terms
- Bidding on derivatives of branded/trademarked terms
- Bidding on broad-match based on branded/trademarked terms
- Bidding on competitors based on branded/trademarked terms
- Direct linking
- Use of brand name in Display URL
- Brand name in Title & Ad Copy
Last changes were recorded on 31.07.2020
Traffic Sources
| Cashback | Forbidden |
| PopUp / ClickUnder | Forbidden |
| SEM | Forbidden |
| Doorway pages | Forbidden |
| Email Marketing | Needs approval |
| Brand bidding | Forbidden |
| Social Media | Needs approval |
| Incentive | Forbidden |
| Toolbar | Forbidden |
| Adult | Forbidden |
| Banner-teaser networks | Allowed |
| YouTube Channel | Needs approval |
| API traffic | Forbidden |
| Lead call | Forbidden |
| Coupon services | Allowed |
| Messengers | Forbidden |
| Loyalty programs | Allowed |
Last changes were recorded on 18.08.2021